REQUEST A DEMO
Total
USD $0.00
Search more companies

Zahravi Pharmaceutical Company Public Joint Stock (Iran)

Main Activities: Medicinal and Botanical Manufacturing
Full name: Zahravi Pharmaceutical Company Public Joint Stock Profile Updated: March 13, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Zahravi Pharmaceutical Company Public Joint Stock is a pharmaceutical company located in Tehran. It was established in 1986 and commissioned in 1991. The company launched a factory with an area of 120,000 square meters, including 28,000 square meters of infrastructure near Shar Tabriz in the East Azerbaijan Province.

Legal Address
18 Km Of Karaj Special Road (Lashgari), Darupakhsh St. - Darupakhsh Factories, Entrance No. 2, No. 23
Tehran; Tehran; Postal Code: 1397116396

Contact Details: Purchase the Zahravi Pharmaceutical Company Public Joint Stock report to view the information.

Website: http://www.zahravipharma.com

Basic Information
Total Employees:
Purchase the Zahravi Pharmaceutical Company Public Joint Stock report to view the information.
Outstanding Shares:
Purchase the Zahravi Pharmaceutical Company Public Joint Stock report to view the information.
Financial Auditors:
Purchase the Zahravi Pharmaceutical Company Public Joint Stock report to view the information.
Incorporation Date:
1984
Key Executives
Purchase this report to view the information.
Chairperson
Purchase this report to view the information.
Vice Chairperson
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Chief Executive Officer
Ownership Details
Purchase this report to view the information.
61.74%
Purchase this report to view the information.
15.84%
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Zahravi Pharmaceutical Company Public Joint Stock report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency IRR. Absolute financial data is included in the purchased report.
Net sales revenue
6.68%
Total operating revenue
8.38%
Operating profit (EBIT)
11.96%
EBITDA
10.14%
Net Profit (Loss) for the Period
48.38%
Total assets
-16.95%
Total equity
3.61%
Operating Profit Margin (ROS)
0.97%
Net Profit Margin
0.82%
Return on Equity (ROE)
1.55%
Debt to Equity Ratio
-59.93%
Quick Ratio
-0.01%
Cash Ratio
0.05%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?